Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2025 Earnings Call Transcript November 4, 2025
Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.46, expectations were $0.93.
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Third Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Ray Furey, Rigel’s Executive Vice President, General...
